Kenvue (NYSE: KVUE) stock is down since completing its spin-off from Johnson & Johnson (NYSE: JNJ) in August 2023. But with more than a year of results now in the books, investors have had time to ...

Kenvue KVUE-2.02%decrease; red down pointing triangle has struck a cooperation agreement with Starboard Value, averting a proxy fight with the activist investment firm. Kenvue on Wednesday said it ...

16:41 EST Kenvue (KVUE) files automatic mixed securities shelf See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investment ...

Deep-pocketed investors have adopted a bearish approach towards Kenvue KVUE, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Kenvue KVUE underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the ...

Piper Sandler raised the firm’s price target on Kenvue (KVUE) to $27 from $24 and keeps an Overweight rating on the shares. The firm notes guidance was reiterated, which continues to include ...

Kenvue saw an 8.5% share price increase over the last month, likely influenced by significant board changes and agreement with activist investor Starboard Value. The addition of board members ...

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors ...